Lamprinou2026 - ABCs and DN B Cells

Lamprinou2026 - ABCs and DN B Cells: Two Sides of the Same Coin?

Full citation: Lamprinou, M., Sachinidis, A., & Dimitroulas, T. (2026). Age-associated B cells and double-negative B cells: two sides of the same coin? The answer depends on the context. Frontiers in Aging, 7, 1752452. https://doi.org/10.3389/fragi.2026.1752452

Raw file: [[raw/Lamprinou2026.pdf]]

Source type — Opinion piece (secondary/conceptual). This is a short Frontiers in Aging “Opinion” article. It reports no original data; it synthesises published immunophenotypic, functional, and transcriptomic findings and offers the authors’ position on the ABC ↔ DN relationship. Treat every quantitative or mechanistic claim below as attributable to the cited primary source, not to this paper. The taxonomy and several core claims lean heavily on the author group’s own prior work (Sachinidis & Garyfallos 2021; Sachinidis et al. 2020/2023/2024/2025), and author AS disclosed Frontiers editorial-board membership. Weight accordingly.

Summary

This opinion article asks whether age-associated B cells (ABCs) and double-negative (DN) B cells are “two sides of the same coin” or distinct entities, and answers: it depends on the context. The authors synthesise the biology of both populations across aging, autoimmunity, and chronic infection, then argue that one ABC subset — the IgD⁻CD27⁻ fraction — corresponds closely to the DN2 subset, while the broader ABC population (which also contains CD27⁺ and IgD⁺ members) and the non-DN2 DN subsets (DN1, DN3, DN4) cannot be equated. The relationship is therefore one of partial overlap whose extent varies with the inflammatory/pathological context, not identity.

The piece reviews ABCs as a T-bet⁺CD11c⁺ population first defined in aged mice (CD21⁻CD23⁻), driven by endosomal TLR7/TLR9 signalling in combination with IFN-γ and/or IL-21, expanded in SLE/RA/Sjögren’s/SSc/MS and in HIV/HCV/malaria, and increasingly targeted therapeutically (BAFF, CD20, IRF5, JAK, A2a, TNF, IL-6R, ROCK inhibitors). It reviews DN B cells as an IgD⁻CD27⁻ population comprising at least four subsets classified by CXCR5/CD11c/T-bet: DN1 (CXCR5⁺CD11c⁻T-bet⁻), DN2 (CXCR5⁻CD11c⁺T-bet⁺), DN3 (CXCR5⁻CD11c⁻T-bet^low), and DN4 (CXCR5⁺CD11c⁻T-bet⁻).

The central refinement for this wiki: ABC is a heterogeneous superset (per Tangye 2023, comprising CD27⁺ + IgD⁺ + predominantly IgD⁻CD27⁻ cells), and even where ABC and DN2 share the T-bet⁺CD11c⁺ phenotype, comparative transcriptomics (Maul 2021) show ABCs are distinct from DN2 (elevated cytokine/chemokine expression). The “ABC ≈ DN2” equivalence the wiki has used is thus a phenotypic approximation that holds only for the IgD⁻CD27⁻ ABC subset, not a transcriptomic identity. No dengue data appear in this paper.

Study Design

• Type: Opinion / narrative conceptual synthesis (no systematic search, no original data, no meta-analysis).
• Sample size: N/A (secondary source).
• Setting: N/A. Evidence spans murine and human studies in aging, systemic autoimmunity (SLE, RA, SS, SSc, MS), and chronic infection (HIV, HCV, malaria, COVID-19).
• Population: N/A. Dengue is not discussed.

Key Findings

All findings below are claims the opinion article makes by citing primary literature; the citing source is named in parentheses.

Age-associated B cells (ABCs):

• First identified in aged mice as CD19⁺CD21⁻CD23⁻ cells expressing T-bet and the integrin CD11c; rare in the young, steadily increasing with age (Hao 2011). A subset shows reduced BCR-mediated antibody production, consistent with immunosenescence, while retaining other immune functions (Cancro 2020).
• Differentiation programme: heightened responsiveness to endosomal TLR7 and TLR9; driven to differentiate by TLR stimulation plus IFN-γ and/or IL-21. IL-21 robustly induces CD11c; IFN-γ primarily promotes T-bet (Cancro 2020; Liu 2024; Naradikian 2016). BCR signalling contributes (with TLR/IFN-γ/IL-21/CD40) but is insufficient to drive differentiation alone (Rubtsov 2017; Imabayashi 2025). TLR7 is X-linked, offered as a partial explanation for the female bias in autoimmunity (Sachinidis 2020).
• Transcriptomics (murine): ABCs are a discrete subpopulation, distinct from B1 and follicular B cells; high CD11c and T-bet plus Ig heavy-chain and CD138 transcripts, with intermediate expression of plasma-cell-differentiation TFs — interpreted as probable plasma-cell precursors (Rubtsov 2011). In autoimmunity, IL-21-inducible genes and cell-adhesion genes are strongly upregulated (Wang 2018).
• ABCs are transcriptomically distinct from other CD11c⁺ B cells, including DN2 — they show elevated expression of multiple cytokines/chemokines not increased in other CD11c⁺ subsets (Maul 2021). (This is the key qualifier on any ABC = DN2 equivalence.)
• Heterogeneous composition: ABCs comprise CD27⁺ B cells, IgD⁺ B cells, and — predominantly — IgD⁻CD27⁻ (DN) cells (Tangye 2023). Most ABCs are class-switched (IgG or IgA), but scRNA-seq reveals the population also contains unswitched IgD⁺ cells (Ambegaonkar 2022). IgD⁺ ABCs are not naive cells — they carry somatic hypermutation and are clonally related to IgD⁻ cells, indicating prior antigen experience (Maul 2021).
• Origin debated: a GC-experienced origin is proposed for at least a subset (diverse Ig repertoire, SHM, antigen-driven activation), but homeostatic proliferation and other GC-independent/extrafollicular routes are not excluded (Cancro 2020).
• Effector functions beyond antibody: pro-inflammatory cytokine/chemokine production, antigen presentation with strong phagocytic capacity, and T-cell activation (Xie 2025).
• Disease associations: premature expansion in SLE, RA, Sjögren’s, and SSc, in some cases correlating with disease activity, autoantibody titres, and organ involvement; T-bet⁺ B cells correlate with SLE activity index and lupus nephritis (potential biomarker); ABC-like cells contribute to SSc vascular complications; ABCs expand with an upregulated inflammatory profile in MS; chronic HIV/HCV/malaria induce similar expansions (Sachinidis 2020/2025; Kourkouni 2024; SoRelle 2025; Portugal 2017; Knox 2017).
• Therapeutics: BAFF inhibition (belimumab) and CD20 depletion (rituximab) reduce ABC frequencies in SLE blood; an extended portfolio includes IRF5 inhibitors, JAK inhibitors (baricitinib), adenosine A2a-receptor agonists, TNF inhibitors, tocilizumab (anti-IL-6R), and ROCK inhibitors (fasudil) (Sachinidis 2024/2025; Ramsköld 2019).

Double-negative (DN) B cells:

• Defined by absence of IgD and CD27; expanded in the elderly; functionally variable by disease (exhausted phenotype in HIV/malaria; principal autoantibody source in SLE) (Sachinidis & Garyfallos 2021; Jenks 2018; Beckers 2023).
• Four-subset taxonomy (by CXCR5 / CD11c / T-bet): DN1 (CXCR5⁺CD11c⁻T-bet⁻; healthy elderly, immunosenescence, relatively non-pathogenic, memory-like transcriptome); DN2 (CXCR5⁻CD11c⁺T-bet⁺; the only DN subset highly expressing T-bet; TLR7-hyper-responsive EF pre-plasmablast; active SLE, esp. African-American women with lupus nephritis); DN3 (CXCR5⁻CD11c⁻T-bet^low; proliferation + unfolded-protein-response signature, lowest CD22/CD72/CD69/BAFFR; severe COVID-19/hypoxia, IgG4-related fibrosis, SLE activity); DN4 (CXCR5⁺CD11c⁻T-bet⁻; poorly defined; allergy-associated; Notch-signalling + protein-ubiquitination genes) (Sachinidis & Garyfallos 2021; Somers 2022; Castleman 2022; Allard-Chamard 2023; Chizzolini 2024; Wing 2023).
• DN1 and DN4 are CXCR5⁺ (vs CXCR5⁻ DN2/DN3); DN2 and DN3 are the subsets most associated with autoimmunity and extrafollicular responses. The authors conclude every DN subpopulation is a discrete entity (Chung 2023).
• Only DN2, among DN subsets, efficiently differentiates into plasma cells (Jenks 2018) — autoantibody production being a hallmark ABC function.

ABC ↔ DN relationship (the paper’s thesis):

• Similarities: both expand in aging, infection, and autoimmunity; overlapping CD11c/T-bet phenotype; shared activation requirements (IFN-γ, IL-21, TLR7/9); drugs that reduce ABCs also reduce DN frequencies; ABC and DN frequencies correlate in both health and lupus (Sachinidis 2025; Chizzolini 2024).
• Differences: some ABCs express CD27 (absent from DN); ABCs are predominantly class-switched whereas the DN definition is isotype-agnostic; DN1/DN3/DN4 lack CD11c and T-bet (defining ABC features); only DN2 efficiently makes plasma cells; ABCs are commonly thought GC-experienced whereas DN cells are strongly tied to extrafollicular differentiation; and ABCs are transcriptomically distinct even from DN2 (Maul 2021).
• Murine vs human framing: in recent literature “ABC” denotes murine cells and human “DN B cells — particularly DN2” are regarded as the counterpart (Chung 2023; Ricker 2021; Satterthwaite 2021), though ABC-like cells are also reported in humans.
• Conclusion: one ABC subset — lacking IgD and CD27 — closely corresponds to DN2; CD27⁺ and IgD⁺ ABCs cannot be classified as DN, and DN cells lacking CD11c/T-bet cannot be classified as ABCs. The extent of correspondence is context-dependent.

Methods Used

N/A — Opinion piece; no primary methods. Cited primary data derive from flow cytometry, single-cell RNA-seq, and IgH-repertoire analyses (reviewed, not re-analysed here).

Entities Mentioned

Age-Associated B Cell, Double-Negative B Cell, Atypical B Cell, DN2 B Cell, DN3 B Cell, T-bet, CD11c, CXCR5, CD27, IgD, IgG, IgA, TLR7, IL-21, CD20

Concepts Addressed

Extrafollicular Response, Germinal Center, Somatic Hypermutation, Class Switch Recombination

Relevance & Notes

This is the wiki’s first source dedicated specifically to the ABC ↔ DN identity question that the Atypical B Cell umbrella page was built to map. (Note: it is not the wiki’s first review of atypical B cells — Sanz2025 - Human Atypical B Cells Overview is an already-ingested invited review covering the same cluster.) Its main contribution here is to sharpen the umbrella’s synonymy: where the wiki had treated “ABC ≈ DN2,” this paper establishes ABC as a heterogeneous superset whose IgD⁻CD27⁻ subset maps to DN2, while CD27⁺/IgD⁺ ABCs and the CXCR5⁺/T-bet⁻ DN subsets (DN1, DN4) fall outside that overlap.

It converges with Sanz2025 - Human Atypical B Cells Overview on context-dependence and on DN2 being the EF/T-bet⁺ effector, and with Sutton2021 - Alternative Lineage B Cells in Vaccination and Infection on ABC/atypical heterogeneity. It diverges on granularity: this paper (drawing on Somers 2022 / Castleman 2022 / the authors’ own work) uses a four-subset DN taxonomy (adding DN4), whereas Sanz2025 and most wiki pages use three (DN1/DN2/DN3). This is nomenclature drift, not a factual contradiction — but it adds DN4 (allergy-associated) to the wiki’s vocabulary.

No dengue data. Value to the wiki is as a comparative/conceptual anchor for the atypical-cell spine, consistent with the wiki’s SLE/COVID/malaria benchmarking scope. The mechanistic claims (IL-21→CD11c, IFN-γ→T-bet, TLR7/9 + IFN-γ/IL-21 differentiation) reinforce the EF-pathway model already built from Jenks2018/Woodruff2020 and provide the murine ABC literature backbone for it.

Limitations (curator/Claude): (1) Opinion piece, no original data — every claim inherits the strength of its underlying primary source. (2) The DN1–DN4 taxonomy and several central claims are self-referential to the author group; cross-lab validation is incomplete (the same caveat the wiki applies to the Sanz lab’s DN framework). (3) DN4 is explicitly “poorly defined.” (4) Therapeutic claims are listed without effect sizes or trial-quality grading.

Questions Raised

• Is the IgD⁻CD27⁻ ABC subset transcriptomically identical to DN2, or does the Maul2021 “ABC ≠ DN2” cytokine/chemokine distinction persist even within the IgD⁻CD27⁻ fraction? (Requires sorting IgD⁻CD27⁻ ABCs vs DN2 for paired transcriptomics.)
• Does a DN4 (CXCR5⁺CD11c⁻T-bet⁻, allergy-associated) population exist in dengue, and would CXCR5⁺ DN subsets (DN1/DN4) be systematically discarded by CXCR5⁻-focused EF gating?
• Why do murine ABCs resist anti-BLyS/anti-CD20 depletion (Knox 2025) while human SLE ABCs are sensitive (Ramsköld 2018; Faustini 2022)? Species difference, or context/disease-stage difference?
• Does the cytoplasmic-FOXO1⁺ DN population described in SLE (Hritzo Ahye & Golding 2018) correspond to DN2, DN3, or a distinct subset?
• If ABCs are “probable plasma-cell precursors” (Rubtsov 2011) yet the alternative-lineage data show no PC-maintenance genes (Sutton2021 - Alternative Lineage B Cells in Vaccination and Infection), is the PC-precursor identity context-dependent (chronic TLR7) as proposed for DN2?